Impact of Administering Intravenous Azithromycin within 7 Days of Hospitalization for Influenza Virus Pneumonia: A Propensity Score Analysis Using a Nationwide Administrative Database

The potential antimicrobial and anti-inflammatory effectiveness of azithromycin against severe influenza is yet unclear. We retrospectively investigated the effect of intravenous azithromycin administration within 7 days of hospitalization in patients with influenza virus pneumonia and respiratory f...

Full description

Bibliographic Details

Published in:	Viruses
Main Authors:	Takatomo Tokito, Takashi Kido, Keiji Muramatsu, Kei Tokutsu, Daisuke Okuno, Hirokazu Yura, Shinnosuke Takemoto, Hiroshi Ishimoto, Takahiro Takazono, Noriho Sakamoto, Yasushi Obase, Yuji Ishimatsu, Yoshihisa Fujino, Kazuhiro Yatera, Kiyohide Fushimi, Shinya Matsuda, Hiroshi Mukae
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Subjects:	azithromycin seasonal influenza virus COVID-19 coronavirus disease acute respiratory distress syndrome infection
Online Access:	https://www.mdpi.com/1999-4915/15/5/1142